In patients over 40, AEA levels were positively associated with neutrophil activation markers such as NE and NGAL, suggesting its role as an early biomarker of HPS-PF that may detect disease activity before conventional lung function metrics like FVC show significant decline. This evidence concerns the gene LCN2 and Hermansky-Pudlak syndrome.